HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit
Research To Practice | Oncology Videos · Dr. Neil Love
April 13, 20251h 59m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Aditya Bardia, Dr Virginia F Borges, Dr Harold J Burstein and Dr Joyce O'Shaughnessy, including the following topics:
- Introduction (0:00)
- CDK4/6 Inhibitors for HR-Positive Metastatic Breast Cancer (mBC) — Dr Borges (9:56)
- Targeting the PTEN/PI3K/AKT Pathway in HR-Positive mBC — Dr Burstein (35:20)
- Role of Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive mBC — Dr O'Shaughnessy (1:03:07)
- Antibody-Drug Conjugates for HR-Positive mBC — Dr Bardia (1:36:12)